Caring about bone-modifying agents (BMAs) in women with early-stage breast cancer
- PMID: 32953838
- PMCID: PMC7475458
- DOI: 10.21037/atm.2020.03.210
Caring about bone-modifying agents (BMAs) in women with early-stage breast cancer
Conflict of interest statement
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm.2020.03.210). The author has no conflicts of interest to declare.
Comment on
-
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.Lancet Oncol. 2020 Jan;21(1):60-72. doi: 10.1016/S1470-2045(19)30687-4. Epub 2019 Dec 2. Lancet Oncol. 2020. PMID: 31806543 Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources